ABSTRACT
Cyclic AIP cANIP has a clearly defined role as a "second messenger" in the action of many hormones (1) . Since all normal cells contain cAMP, it seems likely that the cyclic nucleotide serves other roles as well. A question of particular interest is whether cA.MP metabolism is altered in cancer. cAMIP and its derivative, V6,02 '-dibutyryl cyclic ANIP [(But)2-cAMIP] inhibit the growth of several types of tumor cells, but not the parent, untransformed cells (2) . Also, polyoma-transformed cells appear to have less adenyl cyclase than the untransformed parent cells (3) . These findings suggest that cAMP may have a role in the altered properties of tumor cells.
Fibroblasts Fresh aqueous solutions of (But)2-cAMP (Schwarz Biochemicals) had a strong odor characteristic of butyric acid, suggesting that the relatively unstable 02'-butyryl ester group was hydrolyzed, and some preparations were found to be a mixture of (But)2-cAMP and N-But-cAMP. Therefore, the residual (But)2-cAMP was converted to N-But-cAMP by treatment with alkali, and the butyric acid was removed by extraction with ether (4) . Other samples of (But)2-cAMP contained little N-But2-cAMIP but large quantities of butyric acid. The latter was removed by extraction with ether. The concentration of N-But-cAIP was determined using the absorbance at 272 nm and the molar extinction of 15,100 (4).
RESULTS
Characteristics of normal, transformed, and (But)2-cAMPand N-But-cAMP-treated cells
The morphological characteristics of untransformed mouse fibroblasts are shown in Fig. 1 . The cells typically have elongated cell bodies and distinct narrow processes. As they multiply and crowd together, they line up with the long axis of each cell body in parallel alignment. However, L-929 cells [a mouse fibroblast line chemically transformed by 3-methyleholanthrene "in vitro" (5)] show altered morphological and growth characteristics. As they multiply and crowd together, they lose their elongated cell bodies and narrow processes and become polygonal in shape. Extensive piling up of the cells is observed with prolonged incubation (Fig. 2) . However, during treatment with N-But-cAMP (1 miM) the cells regain several of the morphological and growth characteristics of normal fibroblasts (Fig. 3) No alterations in the morphology of various cell lines of epithelial origin are observed even upon treatment for up to 4 days. Those tested are the African green monkey kidney (VERO), HeLa, human choriocarcinoma (7), and mouse mammary tumor cell lines. This finding suggests that the effect may be specific for transformed cells of fibroblastic origin.
Specificity of the effector
Commercial samples of (But)2-cAMP produce the same morphological changes as N-But-cAMP. However, such preparations are often a mixture of (But)2-cAMP, N-But-cAMP, and butyrate. Therefore, we decided to perform our studies with both (But)rcAMP and N-But-cAMP, which is a more stable compound. In a typical experiment with XC cells, some morphologic alterations occur at concentrations as low as 0.1 mM N-But-cAMP and increasing effects are noted up to 1 mM. cAMP has a small effect but usually only at concentrations of 7 mM.
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A number of other purines were tested over a range of 1-7 mM and over a period of [1] [2] [3] [4] days. ADP (1-7 mM) is ineffective. ATP (1-3 mM) has no effect, but 7 mM ATP causes extensive cell death after 48 hr. AMP, adenosine, and adenine at 1 mM have no effect, but at 3-7 mM promote extensive formation of granules and vacuoles in the cells as well as cell death. After 4 days, a few surviving cells have irregular cell outlines and occasional long processes. The appearance is quite different from the N-But-cAMP-treated cells. Theophylline (1 mM) in combination with 3 mM AMP or ADP is also ineffective.
Epinephrine and isoproterenol (10-6-10-4 M) are ineffective when tested alone or with 1 mM theophylline. Sodium butyrate affects cell morphology, but its effects are easily distinguished from those of N-But-cAMP (Fig. 8) (14) . Each number represents an average of 3 or 4 determinatein at that time. Table 1 shows the results of these studies. Treatment with 1.2 mM N-But-cAMP does not significantly alter the rate of DNA, RNA, or protein synthesis. However, N-But-cAMP at 1 mM was found to inhibit the doubling time of the cells by about 40%. Presumably, if we waited longer to measure DNA, RNA, or protein synthesis, these would have been decreased. Microtubular proteins have several functions in mammalian cells. Among these are the formation of spindle fibers in mitosis and an ectoplasmic "cytoskeleton" which may govern the external cellular configuration (8) . Microtubular proteins may also be involved in cell spreading and motility (9) , and in the formation and maintenance of cell processes (10) . Certain naturally occurring alkaloids preferentially bind to microtubular proteins and disrupt their extended structures. One of these, colchicine, was tested. At a concentration of 5 or 50 ug/ml, colchicine prevents the development of processes in XC cells treated with N-But-cAMP. If Proc. Nat. Acad. Sci. USA movement), is found upon contact of such cells with each other (11) . As a consequence of this inhibition, the cells tend to orient in parallel arrays. Further, for poorly understood reasons, growth and cell division cease at confluency, i.e., when all the available surface is covered with cells. This is commonly referred to as contact inhibition of growth (12) . In general, tumor cells and transformed cells display less contact inhibition of movement and growth, and cell division does not cease at confluency. Frequently, such cells lose their spindly appearance and distinct narrow processes, become polygonal, and extensive piling up of the cells is observed.
Transformed fibroblasts treated with (But)2-cAMP and NBut-cAMP acquire some morphologic characteristics of untransformed cells. They develop a more spindly appearance with an elongated cell body and distinct long narrow processes, arrange in parallel arrays, and show a decreased tendency to become polygonal and pile up. This response clearly requires protein synthesis, involves microtubular proteins, and is freely reversible upon removal of the effector.
The mechanisms for contact inhibition of cell movement or cell growth are unknown, but an "emitter-acceptor" mechanism has been suggested (13) . This model requires that when cells grow close together or come in contact with one another, a signal is transferred from one cell to the next. Possibly, transformed cells are deficient in either the emitter or the acceptor function. We suggest that the signal for inhibition of cell movement and growth may be mediated through cAMP in normal cells. Cell contact may activate adenyl cyclase by means of a diffusable substance on the plasma membrane or through a direct contact of membrane components. This would lead to elevated concentrations of cAMP, which in turn affect cell movement or growth. Transformed cells could be altered in this function by a decrease in adenyl cyclase activity, a lack of the appropriate diffusable substance, or by altered surface properties that make the proper contacts impossible or inefficient. Cell morphology at low cell densities could be influenced by substances in the growth medium which would alter cyclic AMP levels. Measurements of cyclic AMP concentrations in normal and transformed cells are needed to evaluate this hypothesis.
